Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs
The Federal Select Agent Program, part of the Centers for Disease Control and Prevention Division of Select Agents and Toxins, ...
Tag: HHS
BugSeq Awarded BARDA DRIVe Funding to Develop Next-Gen Diagnostics for Any Respiratory RNA Virus
BugSeq Bioinformatics, a biotech company developing next-generation microbiology assays, has entered a public-private partnership with the U.S. Biomedical Advanced Research ...
ORISE Research Fellowship for Advancing CBRN Medical Countermeasures
The Biomedical Advanced Research and Development Authority (BARDA) is seeking students and post-graduate fellows through the Oak Ridge Institute for ...
On Demand Pharmaceuticals Opens State-of-the-Art Manufacturing Facility in Maryland
Agile biomanufacturing technology incubated by DARPA reaches commercial facility milestone On Demand Pharmaceuticals, Inc. (ODP) announced on Feb. 15 the ...
U.S. Purchases 600,000 Courses of Eli Lilly Monoclonal Antibody That Works Against Omicron
The U.S. Department of Health and Human Services (HHS) announced on Feb 10. it will acquire 600,000 treatment courses of ...
Medical Countermeasures Surge Capacity Act of 2022 Introduced in Senate
U.S. Senators Mitt Romney (R-UT) and Maggie Hassan (D-NH), members of the Health, Education, Labor, and Pensions (HELP) Committee, today ...
US Government Invests in At-Home Single Swab Combined Flu, COVID Test
Detect Inc.'s over-the-counter home test identifies and distinguishes between SARS-CoV-2 and influenza A and B nucleic acid in less than ...
Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment
Elusys Therapeutics, which is being acquired by Heat Biologics, has finalized a contract with the U.S. Department of Health and Human Services ...
Why Moderna Won’t Share Rights to the COVID-19 Vaccine with the Government That Paid for Its Development
A quiet monthslong legal fight between the U.S. National Institutes of Health and drugmaker Moderna over COVID-19 vaccine patents recently ...
U.S. Plans to Expand Regional Ebola and Other Special Pathogen Treatment Centers
The U.S. Department of of Health and Human Services Assistant Secretary for Preparedness and Response (ASPR) has announced a forecasted ...
CBRNE Mass Casualty: Rapid Bedside Ultrasound Triage System Awarded BARDA Investment
A portable, radiation-free alternative for fracture screening may help reduce the need for limited X-rays resources – the equipment, as ...
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
Disaster Medicine: New Resource Prepares for Sepsis Encountered in Austere Conditions
Medical responders have a new resource at their disposal to help in identifying and treating sepsis patients in resource-limited environments: ...
BARDA Seeks Applications for Developing At-Home COVID-19 Diagnostics and Technologies
The U.S. Government program is now accepting submissions to develop diagnostics to detect SARS-CoV-2 acute infection as part of a ...
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
The effort will leverage Partner Therapeutics’ prior experience developing Leukine for Acute Radiation Syndrome The contract award supports development of ...
Leidos Awarded DARPA Contract for Personalized Protective Biosystem Against Chemical and Biological Threats
Personalized Protective Biosystem (PPB) program aims to develop technology that reduces the need for burdensome protective equipment while increasing individual ...
Aidar Health’s Rapid Patient Triage System Gains Federal Funding From BARDA
BARDA is collaborating with Aidar Health, Inc. to develop and validate the company’s Aidar COVID-19 decompensation index (AIDI), a new ...
BARDA-NCATS Partner with Vunjak-Novakovic Laboratory at Columbia University on Tissue-Chip Technology
BARDA's Division of Research, Innovation, and Ventures (DRIVe) and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes ...
Harvard’s Wyss Institute Receives Funding to Advance ‘Vaccination-on-a-chip’ Technology
The award will fund the development of human Organ Chips with automated in-line sensors to study vaccine responses The Wyss ...
HHS Taps Draper to Develop Lung-on-a-Chip Technology to Study SARS-CoV-2
Draper has received a $719,000 federal contract from the U.S. Department of Health and Human Services (HHS) to enhance the ...
